Chargement en cours...

Resistance to Raf inhibition in cancer

The use of small molecule BRAF inhibitors has revolutionized the treatment of advanced melanoma. Despite this, resistance is commonplace and associated with a median progression-free survival of >5 months. Major resistance mechanisms include reactivation of the MAPK pathway and increased PI3K/AKT...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Haarberg, H. Eirik, Smalley, Keiran S.M.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4031441/
https://ncbi.nlm.nih.gov/pubmed/24847650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ddtec.2013.12.004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!